Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print July 22, 2008
DOI: 10.2337/db08-0753

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db08-0753v1
57/10/2858    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Concannon, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Concannon, P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3

Patrick Concannon1,2, Suna Onengut-Gumuscu2,3, John A. Todd4, Deborah J. Smyth4, Flemming Pociot5, Regine Bergholdt5, Beena Akolkar6, Henry A. Erlich7, Joan E. Hilner8, Cécile Julier9, Grant Morahan10, Jørn Nerup5, Concepcion R. Nierras11, Wei-Min Chen2,12, Stephen S. Rich2, and the Type 1 Diabetes Genetics Consortium

1Department of Biochemistry and Molecular Genetics,
2Center for Public Health Genomics, and
3Department of Medicine, Division of Endocrinology and Metabolism, University of Virginia, Charlottesville, Virginia, USA
4Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK
5Steno Diabetes Center, Gentofte, Denmark
6Division of Diabetes, Endocrinology, and Metabolic Diseases, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD
7Roche Molecular Systems, Alameda, CA, USA
8Division of Public Health Sciences, Wake Forest University Health Sciences, Winston-Salem, NC, USA
9Inserm U730 et CEA, Institut de Génomique Centre National de Génotypage, Evry, France
10Centre for Diabetes Research, The Western Australian Institute for Medical Research, and Centre for Medical Research, University of Western Australia, Australia
11Juvenile Diabetes Research Foundation, New York, NY, USA
12Department of Public Health Sciences, Division of Biostatistics and Epidemiology, University of Virginia, Charlottesville, VA, USA

Objective.: The Type 1 Diabetes Genetics Consortium (T1DGC) has assembled and genotyped a large collection of multiplex families for the purpose of mapping genomic regions linked to type 1 diabetes. In the current study, we tested for evidence of loci associated with type 1 diabetes utilizing genome-wide linkage scan data and family-based association methods.

Research Design and Methods: A total of 2,496 multiplex type 1 diabetes families were genotyped with a panel of 6,090 SNPs. Evidence of association to disease was evaluated by the pedigree disequilibrium test (PDT). Significant results were followed up by genotyping and analyses in two independent sets of samples: 2,214 parent-affected child trio families and a panel of 7,721 cases and 9,679 controls.

Results: Three of the SNPs most strongly associated with type 1 diabetes localized to previously identified type 1 diabetes risk loci: INS, IFIH1, and KIAA0350. A fourth strongly associated SNP, rs876498 (P=1.0x10-4) occurred in the sixth intron of the UBASH3A locus at chromosome 21q22.3. Support for this disease association was obtained in two additional independent sample sets, type 1 diabetes families (OR=1.06, 95%CI=1.00-1.11, P=0.023) and cases and controls (OR=1.14, 95%CI=1.09-1.19, P=7.5x10-8).

Conclusions: The T1DGC 6K SNP scan and follow-up studies reported here confirm previously reported type 1 diabetes associations at INS, IFIH1 and KIAA0350 and identify an additional disease association on chromosome 21q22.3 in the UBASH3A locus (OR=1.10, 95% CI=1.07-1.13, P=4.4x10-12). This gene and its flanking regions are now validated targets for further re-sequencing, genotyping and functional studies in type 1 diabetes.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.